Ripertamab

Tax included
Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL).
MedChemExpress 
HY-P99952

Data sheet

Size
Multiple sizes
Reactivity
CD20
CAS
2249927-04-4